In a previous study, it was found that EA could improve the local androgen excess environment in the ovaries by regulating protein and mRNA expression of P450arom and P450c17α in the ovarian tissue of rats with PCOS and by improving the reproductive endocrine and metabolic disorders associated with PCOS [17]. The gene discussed is CYP19A1; the disease is polycystic ovary syndrome.